{
  "url": "https://www.law.cornell.edu/regulations/new-york/10-NYCRR-793.6",
  "title": "N.Y. Comp. Codes R. & Regs. Tit. 10 ยง 793.6 - Infection control",
  "content": "N.Y. Comp. Codes R. & Regs. Tit. 10 ยง 793.6 - Infection control\n\nState Regulations\n\nThe hospice must: (a) implement and enforce an agency wide\nprogram for the surveillance, identification, prevention, control and\ninvestigation of infectious and communicable diseases, which could result in\nstaff, volunteers, visitors, or patients and family members becoming exposed to\nsuch communicable diseases or infections. Such a program shall include: (1)\npolicies and procedures for maintaining\nand documenting an effective infection control program in all settings where\npatients reside, including but not limited to protocols for addressing patient\ncare issues and prevention of infection related to airborne pathogens, infusion\ntherapy, urinary tract care, respiratory tract care, wound care and multi-drug\nresistant organisms; (2)\nfollowing\naccepted standards of practice to prevent transmission of infections and\ncommunicable disease; (3)\nmonitoring staff for compliance with hospice policies and procedures related to\ninfection control; (4)\nprotocols\nfor educating staff, contracted personnel, patients, families and other\ncaregivers in infectious disease transmission, standard precautions and the\nprevention and control of infection; and\n(5)\na specific program for protecting\npatients, staff and families from bi-directional spread of HIV and other blood\nborne pathogens, as specified in subdivision (b) of this section. (b) assure that a program be\nimplemented and enforced for the prevention of circumstances which could result\nin staff, including housekeeping, direct care staff and volunteers, or patients\nand family members becoming exposed to significant risk body substances which\ncould put them at significant risk of HIV infection, as defined in section\n63.1\nof this Title, or other blood\nborne pathogen infection, during the provision of services. Such a program\nshall include: (1)\nuse of scientifically\naccepted protective barriers during job-related activities which involve, or\nmay involve, exposure to significant risk body substances. Such preventative\naction shall be taken by the staff with each patient and shall constitute an\nessential element for the prevention of bi-directional spread of HIV or other\nblood borne pathogens. (2)\nuse of\nscientifically accepted preventive practices during job-related activities\nwhich involve the use of contaminated instruments or equipment which may cause\npuncture injuries; (3)\ntraining at\nthe time of employment and yearly staff development programs on the use of\nprotective equipment, preventive practices, and circumstances which represent a\nsignificant risk for all employees whose job-related tasks involve, or may\ninvolve, exposure to significant risk body substances; (4)\nprovision of personal protective\nequipment for staff which is appropriate to the tasks being performed; and\n(5)\na system for monitoring\npreventive programs to assure compliance and safety. (c) implement and enforce a policy/procedure\nfor the management of individuals who are exposed to significant risk body\nsubstances under circumstances which constitute significant risk of\ntransmitting or contracting HIV or other blood borne pathogen infection. The\npolicy/procedure shall include: (1)\na system\nfor reporting to a designated individual in the hospice any exposure thought to\nrepresent a circumstance which constitutes significant risk of transmitting or\ncontracting HIV or other blood-borne pathogen infection; (2)\nevaluation of the circumstances of a\nreported exposure and services providing follow-up of the exposed individual\nwhich includes: (i) medical and\nepidemiological assessment of the individual who is the source of the exposure, where that individual is known and available; (ii)\nif indicated epidemiologically, HIV or\nother blood-borne pathogen counseling and voluntary testing of the source\nindividual. Disclosure of the HIV status of the source individual can be made, consistent with article 27-F of Public Health Law and Part 63 of this Title, with the express written consent of the protected individual, or a person\nauthorized pursuant to law to consent to health care for the protected\nindividual if such person lacks capacity to consent, or pursuant to court\norder, if the HIV status is not known to the exposed individual; (iii)\nappropriate medical follow-up of the\nexposed individual; and\n(iv)\nassurances for protection of confidentiality for those involved in reported\nexposures. Notes\nN.Y. Comp. Codes R. & Regs. Tit. 10\nยง\n793.6\n\nAmended\n\nNew\n\nYork State Register August 31, 2016/Volume XXXVIII, Issue 35, eff. 8/31/2016\n\nState regulations are updated quarterly; we currently have two versions available. Below is a\ncomparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare. No prior version found.",
  "url_type": "regulation",
  "source_index": 20127
}